このアイテムのアクセス数: 47
このアイテムのファイル:
| ファイル | 記述 | サイズ | フォーマット | |
|---|---|---|---|---|
| jdi.14366.pdf | 573.85 kB | Adobe PDF | 見る/開く |
| タイトル: | Toward a cure for diabetes: iPSC and ESC-derived islet cell transplantation trials |
| 著者: | Fujikura, Junji    https://orcid.org/0000-0002-9668-8174 (unconfirmed)Anazawa, Takayuki https://orcid.org/0000-0002-7625-5750 (unconfirmed)Toyoda, Taro Ito, Ryo Kimura, Yasuko Yabe, Daisuke https://orcid.org/0000-0002-5334-7687 (unconfirmed) |
| 発行日: | 22-Nov-2024 |
| 出版者: | Wiley Asian Association for the Study of Diabetes (AASD) |
| 誌名: | Journal of Diabetes Investigation |
| 抄録: | Advancements in regenerative medicine, particularly through the use of induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), are garnering substantial attention as potential solutions to the limited availability of donors, leading to prolonged waiting periods for people with type 1 diabetes who require transplantation of pancreatic islets from deceased donors. The promising outcomes from recent clinical trials suggest that transplantation of iPSC- or ESC-derived islet cells could pave the way for more effective and broadly accessible treatment options. This progress holds potential not only for individuals with type 1 diabetes but may also extend to type 2 diabetes treatment in the future. |
| 著作権等: | ©2024 The Author(s). Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| URI: | http://hdl.handle.net/2433/292200 |
| DOI(出版社版): | 10.1111/jdi.14366 |
| PubMed ID: | 39575893 |
| 出現コレクション: | 学術雑誌掲載論文等 |
このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス
